Industry funded trials…

In this analysis of 546 drug trials registered at, 2/3 were funded by industry, which were more likely to publish positive results, and were less likely to be published within 2 years of study completion (compared to studies funded by government or nonprofit organizations). This findings raise suspicion for publication bias of industry funded studies (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment